Methodology

Last updated: April 17, 2026

Embody is structured around commercial pages, topic hubs, and proof pages rather than a generic homepage-plus-blog setup. The goal is to help visitors understand treatment pathways, site trust signals, and the referral model before they click through.

1. Page architecture

• Homepage for category framing, product-card comparison, and direct intake CTAs
• Solution pages for the two core Embody paths: semaglutide and tirzepatide weekly injections
• Topic hubs for broader questions around workflow, medication comparison, and cost or support concerns
• Proof pages for methodology, editorial standards, evidence review, authorship, and company context

2. Commercial page rules

Each commercial page is expected to do one job well:

• Match one dominant user intent
• Explain the process before the CTA
• Link to policy and trust pages where those questions matter
• Avoid guaranteed-outcome claims or language that outruns provider review

3. Evidence and policy standards

Educational pages are planned and updated under the editorial and evidence review policies. Those pages exist to make sourcing, claim style, and correction practices visible to readers.

• Editorial Policy
• Evidence Review Policy
• Author Profiles
• Evidence Review Team

4. Internal linking logic

• Home links to the most important solutions and hubs
• Solution pages link to relevant hubs and proof pages
• Hub pages link onward to the correct commercial page and supporting proof pages
• Policy and profile pages stay reachable through navigation, footer links, and trust sections

5. Disclosure model

The site is designed to make the intake, provider-review, and treatment-delivery boundary visible. Licensed providers still make medical decisions, and the public-facing pages are written to keep that separation clear.

6. Launch notes

Quick intake, provider review, and delivery only if treatment is approved.